JH, W., H, Q., XC, W., HT, H., GW, H., & Q, Y. (2025). Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced perivascular adipose tissue dysfunction: Revealing epoxyeicosatrienoic acid as a perivascular adipose tissue-derived relaxing factor. European journal of pharmacology, 1006, 178181. https://doi.org/10.1016/j.ejphar.2025.178181
Chicago Style (17th ed.) CitationJH, Wei, Qi H, Wang XC, Hou HT, He GW, and Yang Q. "Inhibition of Soluble Epoxide Hydrolase Ameliorates Hyperhomocysteinemia-induced Perivascular Adipose Tissue Dysfunction: Revealing Epoxyeicosatrienoic Acid as a Perivascular Adipose Tissue-derived Relaxing Factor." European Journal of Pharmacology 1006 (2025): 178181. https://doi.org/10.1016/j.ejphar.2025.178181.
MLA (9th ed.) CitationJH, Wei, et al. "Inhibition of Soluble Epoxide Hydrolase Ameliorates Hyperhomocysteinemia-induced Perivascular Adipose Tissue Dysfunction: Revealing Epoxyeicosatrienoic Acid as a Perivascular Adipose Tissue-derived Relaxing Factor." European Journal of Pharmacology, vol. 1006, 2025, p. 178181, https://doi.org/10.1016/j.ejphar.2025.178181.